Whole-virion influenza vaccine recalls an early burst of high-affinity memory B cell response through TLR signaling

Journal of Immunology

Volumn 196, Issue 10, 2016, Pages 4172-4184

  Onodera, Taishi ^a   Hosono, Akira ^b   Odagiri, Takato ^a   Tashiro, Masato ^a   Kaminogawa, Shuichi ^b   Okuno, Yoshinobu ^c   Kurosaki, Tomohiro ^c,d   Ato, Manabu ^a   Kobayashi, Kazuo ^a,e   Takahashi, Yoshimasa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Institute of Physical and Chemical Research   (Japan)

^e Sakai City Institute of Public Health   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; SPLIT VIRION INFLUENZA VACCINE; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; VIRUS RNA; WHOLE VIRION INFLUENZA VACCINE; MEMBRANE PROTEIN; TLR7 PROTEIN, MOUSE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG TARGETING; HUMORAL IMMUNITY; IMMUNOPHARMACOLOGY; INFLUENZA; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SIGNAL TRANSDUCTION; VIRUS NEUTRALIZATION; ANIMAL; B LYMPHOCYTE; C57BL MOUSE; CELL CULTURE; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; TRANSPLANTATION; VACCINATION; VIRION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; B-LYMPHOCYTES; CELLS, CULTURED; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, VIRAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTOR 7; VACCINATION; VIRION;

EID: 84975048599     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600046     Document Type: Article

References (84)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
2. Plotkin, S. A. 2010. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17: 1055-1065.
3. Fiore, A. E., C. B. Bridges, and N. J. Cox. 2009. Seasonal influenza vaccines. Curr. Top. Microbiol. Immunol. 333: 43-82.
4. Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463.
5. Gross, P. A., and F. A. Ennis. 1977. Influenza vaccine: split-product versus whole-virus types-How do they differ. N. Engl. J. Med. 296: 567-568.
6. Gross, P. A., F. A. Ennis, P. F. Gaerlan, L. J. Denson, C. R. Denning, and D. Schiffman. 1977. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J. Infect. Dis. 136: 623-632.
7. Beyer, W. E., A. M. Palache, and A. D. Osterhaus. 1998. Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature. Clin. Drug Investig. 15: 1-12.
8. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
9. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603.
10. Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS One 2: e863.
11. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
12. Pasare, C., and R. Medzhitov. 2005. Control of B-cell responses by Toll-like receptors. Nature 438: 364-368.
13. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314: 1936-1938.
14. Meyer-Bahlburg, A., S. Khim, and D. J. Rawlings. 2007. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J. Exp. Med. 204: 3095-3101.
15. Koyama, S., T. Aoshi, T. Tanimoto, Y. Kumagai, K. Kobiyama, T. Tougan, K. Sakurai, C. Coban, T. Horii, S. Akira, and K. J. Ishii. 2010. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci. Transl. Med. 2: 25ra24.
16. Hou, B., P. Saudan, G. Ott, M. L. Wheeler, M. Ji, L. Kuzmich, L. M. Lee, R. L. Coffman, M. F. Bachmann, and A. L. DeFranco. 2011. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 34: 375-384.
17. Kasturi, S. P., I. Skountzou, R. A. Albrecht, D. Koutsonanos, T. Hua, H. I. Nakaya, R. Ravindran, S. Stewart, M. Alam, M. Kwissa, et al. 2011. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470: 543-547.
18. Browne, E. P. 2011. Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog. 7: e1002293.
19. Clingan, J. M., and M. Matloubian. 2013. B cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection. J. Immunol. 191: 810-818.
20. Takahashi, Y., H. Hasegawa, Y. Hara, M. Ato, A. Ninomiya, H. Takagi, T. Odagiri, T. Sata, M. Tashiro, and K. Kobayashi. 2009. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. J. Infect. Dis. 199: 1629-1637.
21. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P. J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103: 13789-13794.
22. Ohnishi, K., Y. Takahashi, N. Kono, N. Nakajima, F. Mizukoshi, S. Misawa, T. Yamamoto, Y. Y. Mitsuki, S. Fu, N. Hirayama, et al. 2012. Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Jpn. J. Infect. Dis. 65: 19-27.
23. Onodera, T., Y. Takahashi, Y. Yokoi, M. Ato, Y. Kodama, S. Hachimura, T. Kurosaki, and K. Kobayashi. 2012. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc. Natl. Acad. Sci. USA 109: 2485-2490.
24. Adachi, Y., T. Onodera, Y. Yamada, R. Daio, M. Tsuiji, T. Inoue, K. Kobayashi, T. Kurosaki, M. Ato, and Y. Takahashi. 2015. Distinct germinal center selection at local sites shapes memory B cell response to viral escape. J. Exp. Med. 212: 1709-1723.
25. Ridderstad, A., and D. M. Tarlinton. 1998. Kinetics of establishing the memory B cell population as revealed by CD38 expression. J. Immunol. 160: 4688-4695.
26. Takahashi, Y., H. Ohta, and T. Takemori. 2001. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14: 181-192.
27. Tiller, T., C. E. Busse, and H. Wardemann. 2009. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350: 183-193.
28. Harada, Y., M. Muramatsu, T. Shibata, T. Honjo, and K. Kuroda. 2003. Unmutated immunoglobulin M can protect mice from death by influenza virus infection. J. Exp. Med. 197: 1779-1785.
29. Monsalvo, A. C., J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc, J. Z. Hernandez, B. Maskin, J. Bugna, C. Rubinstein, L. Aguilar, et al. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17: 195-199.
30. Lingwood, D., P. M. McTamney, H. M. Yassine, J. R. Whittle, X. Guo, J. C. Boyington, C. J.Wei, and G. J. Nabel. 2012. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489: 566-570.
31. de Souza, V. A., S. Fernandes, E. S. Araújo, A. F. Tateno, O. M. Oliveira, R. R. Oliveira, and C. S. Pannuti. 2004. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42: 1782-1784.
32. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175: 70-79.
33. Bachmann, M. F., H. Hengartner, and R. M. Zinkernagel. 1995. T helper cellindependent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 25: 3445-3451.
34. Hebeis, B. J., K. Klenovsek, P. Rohwer, U. Ritter, A. Schneider, M. Mach, and T. H. Winkler. 2004. Activation of virus-specific memory B cells in the absence of T cell help. J. Exp. Med. 199: 593-602.
35. Aiba, Y., K. Kometani, M. Hamadate, S. Moriyama, A. Sakaue-Sawano, M. Tomura, H. Luche, H. J. Fehling, R. Casellas, O. Kanagawa, et al. 2010. Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc. Natl. Acad. Sci. USA 107: 12192-12197.
36. Ochsenbein, A. F., D. D. Pinschewer, S. Sierro, E. Horvath, H. Hengartner, and R. M. Zinkernagel. 2000. Protective long-term antibody memory by antigendriven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 97: 13263-13268.
37. Koyama, S., K. J. Ishii, H. Kumar, T. Tanimoto, C. Coban, S. Uematsu, T. Kawai, and S. Akira. 2007. Differential role of TLR-and RLR-signaling in the immune responses to influenza Avirus infection and vaccination. J. Immunol. 179: 4711-4720.
38. Heer, A. K., A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, and B. J. Marsland. 2007. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178: 2182-2191.
39. Cain, D. W., S. E. Sanders, M. M. Cunningham, and G. Kelsoe. 2013. Disparate adjuvant properties among three formulations of "alum". Vaccine 31: 653-660.
40. Eisenbarth, S. C., O. R. Colegio, W. O'Connor, F. S. Sutterwala, and R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
41. Jordan, M. B., D. M. Mills, J. Kappler, P. Marrack, and J. C. Cambier. 2004. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 304: 1808-1810.
42. Kool, M., V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I. M. Bergen, R. Castillo, B. N. Lambrecht, and J. Tschopp. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181: 3755-3759.
43. Lambrecht, B. N., M. Kool, M. A. Willart, and H. Hammad. 2009. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol. 21: 23-29.
44. Li, H., S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
45. Shah, H. B., T. S. Devera, P. Rampuria, G. A. Lang, and M. L. Lang. 2012. Type II NKT cells facilitate Alum-sensing and humoral immunity. J. Leukoc. Biol. 92: 883-893.
46. He, B., R. Santamaria, W. Xu, M. Cols, K. Chen, I. Puga, M. Shan, H. Xiong, J. B. Bussel, A. Chiu, et al. 2010. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 11: 836-845.
47. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
48. Green, N. M., A. Laws, K. Kiefer, L. Busconi, Y. M. Kim, M. M. Brinkmann, E. H. Trail, K. Yasuda, S. R. Christensen, M. J. Shlomchik, et al. 2009. Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J. Immunol. 183: 1569-1576.
49. Tomayko, M. M., N. C. Steinel, S. M. Anderson, and M. J. Shlomchik. 2010. Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185: 7146-7150.
50. Ruben, F. L. 2004. Inactivated influenza virus vaccines in children. Clin. Infect. Dis. 38: 678-688.
51. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature 453: 667-671.
52. Sasaki, S., X. S. He, T. H. Holmes, C. L. Dekker, G. W. Kemble, A. M. Arvin, and H. B. Greenberg. 2008. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 3: e2975.
53. Vollmers, C., R. V. Sit, J. A. Weinstein, C. L. Dekker, and S. R. Quake. 2013. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc. Natl. Acad. Sci. USA 110: 13463-13468.
54. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
55. Zandvoort, A., and W. Timens. 2002. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130: 4-11.
56. Lopes-Carvalho, T., J. Foote, and J. F. Kearney. 2005. Marginal zone B cells in lymphocyte activation and regulation. Curr. Opin. Immunol. 17: 244-250.
57. Dintzis, H. M., R. Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA 73: 3671-3675.
58. Dintzis, R. Z., M. Okajima, M. H. Middleton, G. Greene, and H. M. Dintzis. 1989. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J. Immunol. 143: 1239-1244.
59. Jegerlehner, A., P. Maurer, J. Bessa, H. J. Hinton, M. Kopf, and M. F. Bachmann. 2007. TLR9 signaling in B cells determines class switch recombination to IgG2a. J. Immunol. 178: 2415-2420.
60. Kometani, K., R. Nakagawa, R. Shinnakasu, T. Kaji, A. Rybouchkin, S. Moriyama, K. Furukawa, H. Koseki, T. Takemori, and T. Kurosaki. 2013. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity 39: 136-147.
61. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
62. Bekeredjian-Ding, I. B., M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann. 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174: 4043-4050.
63. Bourke, E., D. Bosisio, J. Golay, N. Polentarutti, and A. Mantovani. 2003. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102: 956-963.
64. Bekeredjian-Ding, I., A. Doster, M. Schiller, P. Heyder, H. M. Lorenz, B. Schraven, U. Bommhardt, and K. Heeg. 2008. TLR9-activating DNA upregulates ZAP70 via sustained PKB induction in IgM+ B cells. J. Immunol. 181: 8267-8277.
65. Corti, D., and A. Lanzavecchia. 2013. Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31: 705-742.
66. Ellebedy, A. H., and R. Ahmed. 2012. Re-engaging cross-reactive memory B cells: the influenza puzzle. Front. Immunol. 3: 53.
67. Bardelli, M., L. Alleri, F. Angiolini, F. Buricchi, S. Tavarini, C. Sammicheli, S. Nuti, E. Degl'Innocenti, I. Isnardi, E. Fragapane, et al. 2013. Ex vivo analysis of human memory B lymphocytes specific for A and B influenza hemagglutinin by polychromatic flow-cytometry. PLoS One 8: e70620.
68. Kaji, T., A. Ishige, M. Hikida, J. Taka, A. Hijikata, M. Kubo, T. Nagashima, Y. Takahashi, T. Kurosaki, M. Okada, et al. 2012. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J. Exp. Med. 209: 2079-2097.
69. Taylor, J. J., K. A. Pape, and M. K. Jenkins. 2012. A germinal centerindependent pathway generates unswitched memory B cells early in the primary response. J. Exp. Med. 209: 597-606.
70. Chan, T. D., S. Gardam, D. Gatto, V. M. Turner, J. Silke, and R. Brink. 2010. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol. Rev. 237: 90-103.
71. Paus, D., T. G. Phan, T. D. Chan, S. Gardam, A. Basten, and R. Brink. 2006. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203: 1081-1091.
72. Victora, G. D., T. A. Schwickert, D. R. Fooksman, A. O. Kamphorst, M. Meyer-Hermann, M. L. Dustin, and M. C. Nussenzweig. 2010. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143: 592-605.
73. Schwickert, T. A., G. D. Victora, D. R. Fooksman, A. O. Kamphorst, M. R. Mugnier, A. D. Gitlin, M. L. Dustin, and M. C. Nussenzweig. 2011. A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J. Exp. Med. 208: 1243-1252.
74. Oropallo, M. A., and A. Cerutti. 2014. Germinal center reaction: antigen affinity and presentation explain it all. Trends Immunol. 35: 287-289.
75. Geeraedts, F., L. Bungener, J. Pool, W. ter Veer, J. Wilschut, and A. Huckriede. 2008. Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Influenza Other Respi. Viruses 2: 41-51.
76. Stephenson, I., K. G. Nicholson, R. Glück, R. Mischler, R. W. Newman, A. M. Palache, N. Q. Verlander, F. Warburton, J. M. Wood, and M. C. Zambon. 2003. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 362: 1959-1966.
77. Geeraedts, F., N. Goutagny, V. Hornung, M. Severa, A. de Haan, J. Pool, J. Wilschut, K. A. Fitzgerald, and A. Huckriede. 2008. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog. 4: e1000138.
78. Hovden, A. O., R. J. Cox, and L. R. Haaheim. 2005. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Scand. J. Immunol. 62: 36-44.
79. al-Mazrou, A., D.W. Scheifele, T. Soong, and G. Bjornson. 1991. Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel. CMAJ 145: 213-218.
80. Nicholson, K. G., D. A. Tyrrell, P. Harrison, C. W. Potter, R. Jennings, A. Clark, G. C. Schild, J. M. Wood, R. Yetts, V. Seagroatt, et al. 1979. Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J. Biol. Stand. 7: 123-136.
81. Mostow, S. R., T. C. Eickhoff, G. A. Chelgren, H. F. Retailliau, and M. Castle. 1977. Studies of inactivated influenza virus vaccines in hospital employees: reactogenicity and absenteeism. J. Infect. Dis. 136(Suppl.): S533-S538.
82. Wright, P. F., J. Thompson, W. K. Vaughn, D. S. Folland, S. H. Sell, and D. T. Karzon. 1977. Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J. Infect. Dis. 136(Suppl.): S731-S741.
83. Szyszko, E., K. Brokstad, R. J. Cox, A. O. Hovden, A. Madhun, and L. R. Haaheim. 2006. Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. Scand. J. Immunol. 64: 467-475.
84. Hess, C., A. Winkler, A. K. Lorenz, V. Holecska, V. Blanchard, S. Eiglmeier, A. L. Schoen, J. Bitterling, A. D. Stoehr, D. Petzold, et al. 2013. T cellindependent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 123: 3788-3796.